Form 8-K - Current report:
SEC Accession No. 0001847903-25-000069
Filing Date
2025-05-14
Accepted
2025-05-14 07:08:34
Documents
16
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20250514.htm   iXBRL 8-K 29106
2 EX-99.1 cntapr-q12025.htm EX-99.1 74593
7 GRAPHIC letterheada.jpg GRAPHIC 60436
  Complete submission text file 0001847903-25-000069.txt   376913

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20250514.xsd EX-101.SCH 2618
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20250514_def.xml EX-101.DEF 16868
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20250514_lab.xml EX-101.LAB 30840
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20250514_pre.xml EX-101.PRE 18275
18 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20250514_htm.xml XML 4497
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 25942607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)